Skeletal Dysplasias
- 16 January 2013
- book chapter
- Published by Springer Nature
- p. 55-72
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Achondroplasia: pathogenesis and implications for future treatmentCurrent Opinion in Pediatrics, 2010
- Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domainJournal of Medical Genetics, 2009
- Systemic Administration of C-Type Natriuretic Peptide as a Novel Therapeutic Strategy for Skeletal DysplasiasEndocrinology, 2009
- Preselection of cases through expert clinical and radiological review significantly increases mutation detection rate in multiple epiphyseal dysplasiaEuropean Journal of Human Genetics, 2006
- The Phenotype of Short Stature Homeobox Gene (SHOX) Deficiency in Childhood: Contrasting Children with Leri-Weill Dyschondrosteosis and Turner SyndromeThe Journal of Pediatrics, 2005
- Efficacy of growth hormone therapy for patients with skeletal dysplasiaJournal of Bone and Mineral Metabolism, 2003
- Growth Hormone and Low Dose Estrogen in Turner Syndrome: Results of a United States Multi-Center Trial to Near-Final HeightThe Journal of Clinical Endocrinology & Metabolism, 2002
- Cyclic Administration of Pamidronate in Children with Severe Osteogenesis ImperfectaNew England Journal of Medicine, 1998
- Calcium metabolism in the jansen type of metaphyseal dysplasiaEuropean Journal of Pediatrics, 1993
- Standard growth curves for achondroplasiaThe Journal of Pediatrics, 1978